TL;DR — Aged garlic extract (AGE) is one of the best-evidenced natural cardiovascular supplements: multiple RCTs show it lowers systolic blood pressure by roughly 5–11 mmHg in people with uncontrolled hypertension, and imaging trials link it to slower coronary calcium progression. The 20-month aging step converts harsh allicin into stable, bioavailable S-allylcysteine — the benefit without the burn or the breath. 600–1,200 mg/day.
What aged garlic extract does (and why it matters)
Blood pressure and arterial plaque are two of the highest-leverage targets in cardiovascular aging, and AGE has genuine human data on both. Beyond lowering BP, imaging work links it to slower coronary calcium and soft-plaque progression — an outcome very few supplements can point to. The aging process (up to 20 months in controlled humidity) trades unstable allicin for stable, water-soluble S-allylcysteine (SAC), giving reproducible dosing and none of the GI harshness of raw garlic.
Primary hallmarks targeted: Altered intercellular communication · Chronic inflammation · Deregulated nutrient sensing
Mechanism — hydrogen sulfide, nitric oxide, and a quieter artery wall
| Pathway | Mechanism | Hallmark link |
|---|---|---|
| H₂S / NO signaling | SAC raises hydrogen-sulfide and nitric-oxide tone → vasodilation, lower peripheral resistance | Altered intercellular communication |
| LDL oxidation | Inhibits LDL oxidation and foam-cell formation; lowers oxidized-phospholipid burden | Chronic inflammation |
| Platelet function | Mild antiplatelet effect → less thrombotic tendency | Altered intercellular communication |
The net effect is multi-pronged action on the drivers of atherosclerosis rather than a single lever.
Evidence summary
| Study | Design | N | Duration | Key outcome | Tier |
|---|---|---|---|---|---|
| Ried 2013 (PMID 23169470) | RCT, dose-response | 79 | 12 wk | Systolic BP −11.8 mmHg vs placebo (2-capsule/day) | B |
| Ried 2010 (PMID 20594781) | RCT | 50 | 12 wk | Systolic BP −10.2 mmHg in uncontrolled hypertension | B |
| Ahmadi/Budoff 2010 (PMID 20152239) | RCT (AGE + supplement) | 60 | 12 mo | Less coronary-artery-calcium progression, better vascular function | B |
| Serrano 2023 (PMID 37686723) | RCT, triple-blind | — | 12 wk | Smaller but significant BP drop with low-dose SAC black-garlic | B |
← Swipe for more columns →
Consensus: For blood pressure in people already on treatment but not at goal, the effect is real and roughly on the order of a first-line lifestyle change. The plaque-progression signal is promising but rests on small trials, several using AGE combined with other supplements — so read it as supportive, not settled.
Where aged garlic disappoints
- Normotensive people — the BP effect is concentrated in those with elevated or uncontrolled pressure; if yours is already normal, expect little movement. - "Detox" and immune claims — the marketing outruns the data; the defensible story is cardiovascular. - Raw-garlic equivalence — allicin-standardized and aged extracts are different products; SAC content, not "allicin potential," is what these trials used.
What would change this grade. The tier is B because the BP evidence is consistent across independent RCTs but the hard-outcome (event) data are indirect. It would rise to A with a large trial showing reduced cardiovascular events, and fall if better-controlled imaging trials failed to reproduce the plaque signal.
Dosing protocol
| Parameter | Recommendation | Notes |
|---|---|---|
| Dose | 600–1,200 mg/day standardized AGE | Standardize to S-allylcysteine, not "allicin potential" |
| Timing | Split with meals | Better tolerance |
| Duration | 12 weeks (BP); 12 months (plaque) | Plaque endpoints are slow |
Add aged garlic to your stack
Pairs with nitrate and flavanol sources for blood pressure — the Stack Architect shows the combined cardiovascular picture.
Open Stack ArchitectMonitoring
| Biomarker | Target | Frequency | Action if off-target |
|---|---|---|---|
| Home systolic BP | Individualized | Baseline, then 4–8 wk | Escalate/deprescribe with your clinician |
| Lipid panel | Individualized | Baseline, 12 wk | Reassess whole regimen |
| Coronary calcium score | Slower progression | Baseline, 12 mo (if plaque is the goal) | Intensify risk-factor control |
← Swipe for more columns →
Safety, red flags, and contraindications
- Very well tolerated — the aged extract avoids most of the GI upset of raw garlic.
- Mild antiplatelet activity — the main practical caution.
Do not self-start without clearance
- Anticoagulant / antiplatelet therapy — additive bleeding risk; clear it with your prescriber.
- Upcoming surgery — stop 7–10 days beforehand per your surgeon.
Who should skip aged garlic
- People on warfarin or DOACs without physician oversight. - Anyone with a bleeding disorder. - Those expecting an immune or "detox" benefit — that's not what the evidence supports.
Synergies and antagonists
Pairs well with:
| Partner | Rationale | Guide |
|---|---|---|
| Beetroot nitrate | Complementary NO pathway for blood pressure | Add both in Stack Architect |
| Cocoa flavanols | Endothelial NO support | Cardiovascular stack |
| Omega-3 / Bergamot | Rounds out lipids + plaque + BP | Cardiovascular stack |
Works against / redundant with: No well-characterized antagonists at typical doses. Stacking several antiplatelet agents (fish oil, high-dose garlic, nattokinase) raises cumulative bleeding risk — coordinate, don't just add.
Personal results template
My aged garlic results log
| Date | Week | Dose | Home SBP | LDL-C | Notes |
|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | Baseline |
| YYYY-MM-DD | 12 | — | — | — | BP endpoint |
| YYYY-MM-DD | 52 | — | — | — | Plaque endpoint |
← Swipe for more columns →
Response criteria (personal, not clinical): - Meaningful: sustained home SBP drop of ≥5 mmHg - Plateau: no change by 12 weeks → reassess the regimen - Adverse: any unusual bruising/bleeding → stop and call your clinician
References
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.